SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Value Investing -- Ignore unavailable to you. Want to Upgrade?


To: Paul Senior who wrote (12675)6/23/2001 10:52:35 AM
From: jhelmers  Read Replies (3) | Respond to of 78525
 
Any thoughts on AGR/A or PHSY

AGR/A, being in the center of the telecom vortex has recently gone from 9 to 5. unlike it's former parent LU, it has no debt and will certainly survive. the word is that of all the fiber which has been laid, only 2.5% has been "lit". as that fiber gets lit, the optical equipment makers will see the biz. this spin out (usually bullish) is cheaper at 2X sales than its competitors. i own some and am contemplating more. thoughts?

PHSY (an HMO)looks cheap on all traditional metrics. it has been hit dramatically as it struggles to change its biz model to hospital risk based contracts. UNH owns 17% of stock, management owns 7%, LT debt is not onerous, seems like very good risk/reward. i don't own this one yet. thoughts?



To: Paul Senior who wrote (12675)6/23/2001 12:51:42 PM
From: Spekulatius  Read Replies (2) | Respond to of 78525
 
I have been swapping my position in BMY for a position in NVS. NVS is a better value right now, IMO. NVS has the major patent expirations behind themselves, while BMY has major obstacles in the near term future: Glucophage, Buspar, Pravachol etc. BMY has everything riding on Vanlev, and will not meet growth targets, if this drug fails. NVS has a similar valuation and financial strength but much less risk.